Kevin Dzobo, Chelene Ganz, Nicholas Ekow Thomford, and Dimakatso Alice Senthebane.OMICS: A Journal of Integrative Biology. ahead of print http://doi.org/10.1089/omi.2020.0185
Kevin Dzobo, Chelene Ganz, Nicholas Ekow Thomford, and Dimakatso Alice Senthebane.OMICS: A Journal of Integrative Biology. ahead of print http://doi.org/10.1089/omi.2020.0185
Kevin Dzobo, Chelene Ganz, Nicholas Ekow Thomford, and Dimakatso Alice Senthebane.OMICS: A Journal of Integrative Biology. ahead of print http://doi.org/10.1089/omi.2020.0185
Kevin Dzobo, Chelene Ganz, Nicholas Ekow Thomford, and Dimakatso Alice Senthebane.OMICS: A Journal of Integrative Biology. ahead of print http://doi.org/10.1089/omi.2020.0185
Abstract
Solid tumors display complex biology and most therapies including chemotherapy cannot prevent therapy resistance and relapse. Most therapeutics target cancer cells, but recent data suggest the presence of cancer stem cells as cells with self-renewal and tumorigenic abilities. Cancer stem cell markers have been suggested to have prognostic value and can be targeted during cancer treatment and in resistant disease. CSCs have been postulated to play significant contextual roles in tumor initiation, progression, therapy resistance and metastasis. CSCs have thus been targeted by new generation cancer drugs. The transcriptional expression of several CSC markers in different cancers was evaluated by searching publicly available The Cancer Genome Atlas (TCGA) and Gene Expression Profiling Interactive Analysis (GEPIA) databases. We report here new findings on expression and prognostic significance of CSC markers in several cancers by examining the expression of CSCs markers in tumor tissues versus the adjacent normal tissues. We found that CSC markers were mostly highly expressed various tumors such as colon, lung, pancreatic and esophageal cancers. No CSC marker is expressed in the same pattern in all cancers and individual CSC marker expression was not linked to patient survival. This analysis calls for continued research on CSCs and clinical evaluation of the CSC markers in relation to prognosis of cancers in large population samples. Novel cancer drugs ought to target CSCs, cancer cells and tumor microenvironment variations.
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
